Clinical trial
A Randomized, Open-label, Multi-center Phase III Study Designed to Evaluate the Safety and Efficacy of E10A in Patients With Recurrent/Unresectable Squamous Cell Carcinoma of the Head and Neck Region
NCT02630264 is registered in ClinicalTrials.gov with Guangzhou Double Bioproducts Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Open-label, Multi-center Phase III Study Designed to Evaluate the Safety and Efficacy of E10A in Patients With Recurrent/Unresectable Squamous Cell Carcinoma of the Head and Neck Region
- Lead sponsor
- Guangzhou Double Bioproducts Co., Ltd
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- June 30, 2013
- Completion date
- December 31, 2016
- Enrollment
- 540 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.